IRBP - PREPARATION AND CHARACTERIZATION OF SITE-SPECIFIC MONOCLONAL-ANTIBODIES

被引:14
作者
DONOSO, LA
RODRIGUES, M
VRABEC, TR
SERY, TW
FONG, SL
机构
[1] WILLS EYE HOSP & RES INST,RETINA SERV,HENRY & CORINNE BOWLER RETINA RES LAB,PHILADELPHIA,PA 19107
[2] UNIV MARYLAND,DEPT OPHTHALMOL,BALTIMORE,MD 21201
[3] PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907
关键词
D O I
10.3109/02713689008999623
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Interstitial retinoid binding protein (IRBP) is a 136,000 molecular weight photoreceptor cell protein which is a highly pathogenic autoantigen for the induction of experimental autoimmune uveitis (EAU). In this study we produced a series of monoclonal antibodies (MAbs) which define different epitopes in the native molecule. These MAbs were further subdivided into three distinct groups based on a radioimmunoassay, and by ELISA assay using native IRBP and synthetic peptides corresponding to its entire amino acid sequence. Group I MAbs (MAbD7-B1 and MAbC6-B4) bound to native IRBP but not to any synthetic peptides, suggesting that their antigenic epitopes are strictly conformation dependent. Group II MAbs (MAbC7-D3 and MAbG8-H4) bound weakly to multiple peptides which shared amino acid sequence similarity located within each of four homology domains indicating that these epitopes are also conformation dependent. In group III (MAbH3-B5, MAbH7-A5, and MAbB6-D12) MAb binding was localized to a specific peptide. The MAbH3-B5 binding site was further refined to amino acid positions 361 to 367 in the native molecule. MAbH3-B5 was also useful in localizing IRBP in the mouse retina by immuno-histochemical techniques. The application of these MAbs in the study of EAU and interphotoreceptor transport mechanisms is discussed. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:357 / 362
页数:6
相关论文
共 14 条
[1]   THE ANTIGENIC STRUCTURE OF PROTEINS - A REAPPRAISAL [J].
BENJAMIN, DC ;
BERZOFSKY, JA ;
EAST, IJ ;
GURD, FRN ;
HANNUM, C ;
LEACH, SJ ;
MARGOLIASH, E ;
MICHAEL, JG ;
MILLER, A ;
PRAGER, EM ;
REICHLIN, M ;
SERCARZ, EE ;
SMITHGILL, SJ ;
TODD, PE ;
WILSON, AC .
ANNUAL REVIEW OF IMMUNOLOGY, 1984, 2 :67-101
[2]  
CHADER GJ, 1983, PROGR RETINAL RES, V2, P163
[3]  
DONOSO LA, 1989, J IMMUNOL, V143, P79
[4]   HUMAN IRBP - CHARACTERIZATION OF UVEITOPATHOGENIC SITES [J].
DONOSO, LA ;
MERRYMAN, CF ;
SERY, TW ;
VRABEC, T ;
ARBIZO, V ;
FONG, SL .
CURRENT EYE RESEARCH, 1988, 7 (11) :1087-1095
[5]  
DONOSO LA, 1985, INVEST OPHTH VIS SCI, V26, P561
[6]  
FONG SL, 1984, J BIOL CHEM, V259, P6534
[7]  
FONG SL, 1988, J BIOL CHEM, V263, P15334
[8]  
FRACKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P489
[9]  
GERY I, 1986, INVEST OPHTH VIS SCI, V27, P1296
[10]  
HIROSE S, 1986, ARCH OPHTHALMOL-CHIC, V104, P1698